未登录

I

Ivan V. Pozhidaev

Russian Academy of Sciences

H指数:14

被引数:422

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

POLYMORPHIC VARIANTS OF INTRACELLULAR REGULATORY PROTEIN GENES AKT1, MAPK, CREB IN THE CLINICAL COURSE OF SCHIZOPHRENIA

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2024-10-010

PRE

NOS1AP Gene Variants and Their Role in Metabolic Syndrome: A Study of Patients with Schizophrenia

IF3.9

2024-03-120

OAAI

Association of rs11644461 GRIN2A with clinical phenotype of schizophrenia

EUROPEAN PSYCHIATRY

IF6.7

2023-07-191

OAAI

Genes of the Glutamatergic System and Tardive Dyskinesia in Patients with Schizophrenia

IF3.3

2022-06-221

OAAI

Pharmacogenetic study to elucidate putative dopaminergic mechanisms of antidepressant action

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2021-12-010

PRE

Gene polymorphisms of hormones regulating metabolism in schizophrenia patients with metabolic syndrome

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2021-12-010

PRE

FTO GENE POLYMORPHISMS AND BODY MASS INDEX IN SCHIZOPHRENIA PATIENTS WITH METABOLIC SYNDROME

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2021-10-010

PRE

GENDER DIFFERENCES IN THE ASSOCIATION OF POLYMORPHIC VARIANTS OF THE 5-HT2C RECEPTOR GENE AND ANTIPSYCHOTIC-INDUCED HYPERPROLACTINEMIA IN PATIENTS WITH SCHIZOPHRENIA

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2021-10-010

PRE

Investigation of the role of polymorphic variants FTO gene in schizophrenia patients with metabolic syndrome

精神分裂症合并代谢综合征患者FTO基因多态性变异的研究

EUROPEAN PSYCHIATRY

IF6.7

2021-08-130

OAAI

Drug-induced metabolic syndrome hasn't associations with 5-HT receptor genes polymorphisms in patients with schizophrenia

EUROPEAN PSYCHIATRY

IF6.7

2021-08-130

OAAI

Lep gene and leptin concentration in serum of schizophrenia patients with metabolic syndrome

EUROPEAN PSYCHIATRY

IF6.7

2021-08-130

OAAI

Preliminary Pharmacogenetic Study to Explore Putative Dopaminergic Mechanisms of Antidepressant Action

JOURNAL OF PERSONALIZED MEDICINE

IF3

2021-07-273

OAAI

Comparative Characteristics of the Metabolic Syndrome Prevalence in Patients With Schizophrenia in Three Western Siberia Psychiatric Hospitals

FRONTIERS IN PSYCHIATRY

IF3.2

2021-07-028

OAAI

Genetic Polymorphisms of 5-HT Receptors and Antipsychotic-Induced Metabolic Dysfunction in Patients with Schizophrenia

JOURNAL OF PERSONALIZED MEDICINE

IF3

2021-03-0512

OAAI

Metabolic syndrome in patients with schizophrenia and the PTPN5 gene encoding the striatal-enriched protein tyrosine phosphatase

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2020-11-010

PREAI

Polymorphisms in BDNF, AKT1, GSK3B genes: possible association with antipsychotic-induced hyperpro-lactinemia in schizophrenia patients

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2020-11-010

OAAI

Metabolic syndrome in schizophrenia and polymorphic variants of CYP1A2 and GSTP1 genes

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2020-11-011

PREAI

5-Hydroxytryptamine Receptors and Tardive Dyskinesia in Schizophrenia

FRONTIERS IN MOLECULAR NEUROSCIENCE

IF3.8

2020-04-249

OAAI

Association between 8 P-glycoprotein (MDR1/ABCB1) gene polymorphisms and antipsychotic drug-induced hyperprolactinaemia

8种P-糖蛋白 (MDR1/ABCB1) 基因多态性与抗精神病药物致高催乳素血症的相关性研究

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

IF3

2020-04-0610

OAAI

Association between prolactin gene polymorphism (-1149 G/T) and hyperprolactinemia in anti-psychotic treated patients with schizophrenia

EUROPEAN PSYCHIATRY

IF6.7

2020-03-230

PREAI